All News
View More
Mistrust, Confusion in Medicare Advantage Plan Members, Survey Says

Although Medicare Advantage plan member satisfaction has dropped, areas for improvement have emerged in the form of digital innovations, according to the J.D. Power 2025 U.S. Medicare Advantage Study.

MHE Week in Review – Different Prices for the Same Procedures, AI Racial Bias in Schizophrenia Diagnoses and More

Here’s what you missed this week on Managed Healthcare Executive.

Postmenopausal Women Aren’t The Only Ones Who Could Benefit From Frequent Standing

The next step for the Rise For Health study researchers is to study the health benefits of frequent standing in older men and women.

A Conversation With Alexa D’Angelo, Ph.D., M.P.H., Recent Doctoral Graduate from the CUNY School of Public Health and Health Policy

Sexual and gender minority individuals still face insurance denials and cost-sharing barriers when accessing pre-exposure prophylaxis (PrEP), despite having a Grade A recommendation from the United States Preventive Services Task Force (USPSTF).

MedImpact To Offer Unbranded Ustekinumab-aekn Biosimilar

The biosimilar will be available to any licensed specialty pharmacy in the United States at a 95% discount from Stelara, starting January 1, 2026.

Schizophrenia Diagnoses Have Highest Likelihood of AI Racial Bias, Study Shows

Large language models (LLMs) were more likely to suggest inferior treatment options when reviewing hypothetical cases when patients' Black identity was listed or implied.

Sitting Less May Be Tied to Lower Blood Pressure in Postmenopausal Women, Study Shows

New study results provide insight into improving heart health through behavior changes, such as taking standing breaks throughout the day.

76% of Autoimmune Patients Receive at Least One Misdiagnosis, Study Shows

A lack of training and vague, overlapping symptoms can be attributed to more than three-quarters of autoimmune patients being misdiagnosed at least once, according to Veena Joy, the U.S. Lead for Strategic Partnerships, Allergy and Autoimmunity at Thermo Fisher Scientific.

New Biomarker Models Offer Mechanistic Insights in Chronic Kidney Disease Management

This recent study underscores the fact that biomarkers serve not merely as statistical instruments but as insights into disease biology.

Official Media Partners